Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

Joana Vitte; Moise Michel; Soraya Mezouar; Aissatou Bailo Diallo; Asma Boumaza; Jean-Louis Mege; Benoit Desnues

doi:10.3389/fimmu.2020.02159

Journal articles

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

Joana Vitte ^{1, 2} Moise Michel ^{1, 2} Soraya Mezouar ^{2, 1} Aissatou Bailo Diallo ^{1, 2} Asma Boumaza ^{1, 2} Jean-Louis Mege ^{1, 2} Benoit Desnues ^{1, 2}

1 MEPHI - Microbes évolution phylogénie et infections

2 IHU AMU - Institut Hospitalier Universitaire Méditerranée Infection

Abstract : The rapid spread, severity, and lack of specific treatment for COVID-19 resulted in hasty drug repurposing. Conceptually, trials of antivirals were well-accepted, but twentieth century antimalarials sparked an impassioned global debate. Notwithstanding, antiviral and immunomodulatory effects of aminoquinolines have been investigatedin vitro, in vivoand in clinical trials for more than 30 years. We review the mechanisms of action of (hydroxy)chloroquine on immune cells and networks and discuss promises and pitfalls in the fight against SARS-CoV-2, the agent of the COVID-19 outbreak.

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-03149722
Contributor : Isabelle Combe <>
Submitted on : Tuesday, February 23, 2021 - 11:53:53 AM
Last modification on : Wednesday, February 24, 2021 - 3:18:50 AM

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

Links full text

Identifiers

Collections

Citation

Export

Metrics

3

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

3